Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84

JCI Insight. 2023 Jan 24;8(2):e165469. doi: 10.1172/jci.insight.165469.

Abstract

Medium-chain triglycerides (MCTs), which consist of medium-chain fatty acids (MCFAs), are unique forms of dietary fat with various health benefits. G protein-coupled 84 (GPR84) acts as a receptor for MCFAs (especially C10:0 and C12:0); however, GPR84 is still considered an orphan receptor, and the nutritional signaling of endogenous and dietary MCFAs via GPR84 remains unclear. Here, we showed that endogenous MCFA-mediated GPR84 signaling protected hepatic functions from diet-induced lipotoxicity. Under high-fat diet (HFD) conditions, GPR84-deficient mice exhibited nonalcoholic steatohepatitis (NASH) and the progression of hepatic fibrosis but not steatosis. With markedly increased hepatic MCFA levels under HFD, GPR84 suppressed lipotoxicity-induced macrophage overactivation. Thus, GPR84 is an immunomodulating receptor that suppresses excessive dietary fat intake-induced toxicity by sensing increases in MCFAs. Additionally, administering MCTs, MCFAs (C10:0 or C12:0, but not C8:0), or GPR84 agonists effectively improved NASH in mouse models. Therefore, exogenous GPR84 stimulation is a potential strategy for treating NASH.

Keywords: G protein–coupled receptors; Hepatology; Inflammation; Macrophages.

MeSH terms

  • Animals
  • Dietary Fats / pharmacology
  • Fatty Acids
  • Liver Cirrhosis
  • Mice
  • Non-alcoholic Fatty Liver Disease*
  • Receptors, G-Protein-Coupled* / agonists
  • Triglycerides

Substances

  • Receptors, G-Protein-Coupled
  • Fatty Acids
  • Dietary Fats
  • Triglycerides
  • Gpr84 protein, mouse